BEAM

Beam Therapeutics Inc.

27.37 USD
+1.75 (+6.83%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Beam Therapeutics Inc. stock is up 13.9% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 July’s closed higher than June. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Jun 18:52 19 Jul, 2024 30.00 CALL 2999 26
21 Jun 16:13 16 Aug, 2024 27.00 CALL 934 93

About Beam Therapeutics Inc.

Beam Therapeutics Inc. develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders.